Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2024 Mar 7;63(3):2301001.
doi: 10.1183/13993003.01001-2023. Print 2024 Mar.

The effect of high altitude (2500 m) on incremental cycling exercise in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: a randomised controlled crossover trial

Affiliations
Randomized Controlled Trial

The effect of high altitude (2500 m) on incremental cycling exercise in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: a randomised controlled crossover trial

Julian Müller et al. Eur Respir J. .

Abstract

Background: Our objective was to investigate the effect of a day-long exposure to high altitude on peak exercise capacity and safety in stable patients with pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH).

Methods: In a randomised controlled crossover trial, stable patients with PAH or distal CTEPH without resting hypoxaemia at low altitude performed two incremental exercise tests to exhaustion: one after 3-5 h at high altitude (2500 m) and one at low altitude (470 m).

Results: In 27 patients with PAH/CTEPH (44% females, mean±sd age 62±14 years), maximal work rate was 110±64 W at 2500 m and 123±64 W at 470 m (-11%, 95% CI -16- -11%; p<0.001). Oxygen saturation measured by pulse oximetry and arterial oxygen tension at end-exercise were 83±6% versus 91±6% and 6.1±1.9 versus 8.6±1.9 kPa (-8% and -29%; both p<0.001) at 2500 versus 470 m, respectively. Maximal oxygen uptake was 17.8±7.5 L·min-1·kg-1 at high altitude versus 20±7.4 L·min-1·kg-1 at low altitude (-11%; p<0.001). At end-exercise, the ventilatory equivalent for carbon dioxide was 43±9 at 2500 m versus 39±9 at 470 m (9%, 95% CI 2-6%; p=0.002). No adverse events occurred during or after exercise.

Conclusions: Among predominantly low-risk patients with stable PAH/CTEPH, cycling exercise during the first day at 2500 m was well tolerated, but peak exercise capacity, blood oxygenation and ventilatory efficiency were lower compared with 470 m.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: None of the authors have any conflicts of interest in relation to this manuscript.

Figures

FIGURE 1
FIGURE 1
Study flowchart. PP: per protocol; ITT: intention to treat.
FIGURE 2
FIGURE 2
Physiological secondary outcomes at rest and at end-exercise, at high versus low altitude: a) oxygen uptake (VO2), b) carbon dioxide production (VCO2), c) ventilatory equivalent for carbon dioxide (minute ventilation (VE)/VCO2), d) oxygen saturation measured by pulse oximetry (SpO2), e) arterial carbon dioxide tension (PaCO2) and f) arterial oxygen tension (PaO2). Box plots represent the medians with corresponding standard deviation; the black dots represent the means with corresponding standard error of measurement. The cloud plots to the right of the box plots represent the data distribution. Statistical significance between high and low altitude: *: p<0.05; **: p<0.01; ***: p<0.001.

Comment in

Similar articles

Cited by

References

    1. Humbert M, Kovacs G, Hoeper MM, et al. . 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 2023; 61: 2200879. doi:10.1183/13993003.00879-2022 - DOI - PubMed
    1. Humbert M, Kovacs G, Hoeper MM, et al. . 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J 2022; 43: 3618–3731. doi:10.1093/eurheartj/ehac237 - DOI - PubMed
    1. McGoon MD, Ferrari P, Armstrong I, et al. . The importance of patient perspectives in pulmonary hypertension. Eur Respir J 2019; 53: 1801919. doi:10.1183/13993003.01919-2018 - DOI - PMC - PubMed
    1. Saxer S, Lichtblau M, Berlier C, et al. . Physical activity in incident patients with pulmonary arterial and chronic thromboembolic hypertension. Lung 2019; 197: 617–625. doi:10.1007/s00408-019-00248-x - DOI - PubMed
    1. Hoeper MM, Apitz C, Grunig E, et al. . Targeted therapy of pulmonary arterial hypertension: updated recommendations from the Cologne Consensus Conference 2018. Int J Cardiol 2018; 272S: 37–45. doi:10.1016/j.ijcard.2018.08.082 - DOI - PubMed

Publication types